Vanderbilt's Master Innovator Recognition Program has announced its 2025 honorees. Robert Carnahan, Darren Engers, Karl Zelik, Kayla Temple and John Wikswo were recognized for their extraordinary contributions to translating research into commercial applications that have significant societal impact.

A new potential treatment for schizophrenia discovered through the Warren Center for Neuroscience Drug Discovery has entered phase 1 clinical trials, marking the fifth WCNDD therapeutic to advance into human testing. NMRA-898 is the second compound being developed by Neumora Therapeutics, Inc. following the entry of WCNDD's NMRA-861 into clinical trials earlier this year. Read More

January 27, 2026  • 12:00–1:00 p.m. • Vanderbilt Alumni Hall Memorial Room

View Lunch & Learn Key Insights: “Can Patents Block My Research? Navigating Innovation and Intellectual Property" led by Alan Bentley, assistant vice chancellor of technology transfer and IP development. 

* includes end-user software and materials licenses along with conventional technology licenses 

The project is intended to bridge the gaps in obesity treatment by leveraging AI technologies at Vanderbilt University Medical Center. The Industry Collaborations team guided Chen towards this opportunity, coached him on best practices, and facilitated connections with the appropriate departments for strategic planning and intellectual property related discussions. Read More

Since the inception of the Ancora Innovations partnership in 2018, Vanderbilt and Deerfield Management have enjoyed a robust collaboration. Recently, key members of Deerfield’s leadership team spent two days at Vanderbilt to engage faculty in discussions about potential projects of mutual interest. Read More

Brian Laden's journey to becoming Appello Pharmaceuticals, Inc.'s CEO began with scientific passion and pivotal career experiences that ultimately brought him to Vanderbilt University. Appello’s evolution from a Vanderbilt lab concept to therapeutic candidate highlights the university's dedication to translating research into impactful treatments. Read Story

January 7, 2026  • 12:30–1:30 p.m. • RSVP Here

Eleven current faculty members at Vanderbilt University and Vanderbilt University Medical Center are on Clarivate's 2025 list of “highly cited researchers” among 7,131 faculty worldwide. 

Their publications rank in the top 1% by citations for their field of research in the Web of Science Core Collection over the past decade. View Full List

12,462,501 – “System and Method for Efficient Redirection of User Interactions and Gestures between Remote and Local Environments in Augmented Reality” (Akshith Ullal, Nilanjan Sarkar, Alexandra Watkins)

12,472,158 – “Methods of Treating Trigeminal Nerve Pain” (Jill Pulley)

12,478,317 – “Method and Device for Measuring or Determining at least One Biomechanical Parameter of Soft Biological Tissues” (Arved Vain, Eric Tkaczyk, Mihkel Poldemaa)

12,478,340 – “Systems and Methods for Pulmonary Perfusion Analysis Using Dynamic Radiography” (Matthew Smith, Gary Smith, Jared Grice)

12,478,445 – “Surgical Device Tip with Deflectable Joint” (Katherine Riojas, Robert Webster, Daniel Rucker, Kaitlin Oliver Butler, Ryan Ponten)